-
The global industrialization base for small molecule innovative drugs in Baiji Shenzhou has been launched
"Suzhou Industrial Park Released" WeChat official account news, on November 16, the global industrialization base of small molecule innovative drugs in Baekje China, located in Suzhou Industrial Park ... -
Baekje Shenzhou Zebtinib ALPINE Research Appears 2023 ASH Latest Follow up Data shows Continuous Benefits
From December 9th to 11th, as one of the largest academic events in the world of hematology, the American Society of Hematology (ASH) Annual Conference was successfully held. During this conference, ... -
Baekje Shenzhou Hong Kong stock fell more than 5%
On the morning of December 21st, the Hong Kong stock of Baekje Shenzhou fell more than 5%, while the A-share of Baekje Shenzhou is now down 2%. -
Why is it rare for BeiGene to sue European and American generic drug patent infringement?
Domestic original pharmaceutical companies have rarely sued European and American generic pharmaceutical companies. On March 8th, BeiGene filed a patent infringement lawsuit against Sanders, MSN Phar ... -
Baekje Shenzhou Tirelizumab has been approved for marketing by the FDA
On March 15th, Baekje announced that the US Food and Drug Administration (FDA) has approved tirizumab as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carc ... -
BeiGene: Tirelizumab Approved for Market by FDA
On March 15th, Securities Daily News reported that BeiGene announced that the company has recently learned that the US Food and Drug Administration (FDA) has approved the company's core product, Tera ... -
Luckin Coffee v. Shenzhou Youche Case Goes to Court Today
Southern Finance and Economics, May 6th (Xinhua) - According to Tianyancha's legal lawsuit information, a new court hearing announcement has been added for the contractual fault liability dispute bet ... -
BeiGene: Chief Financial Officer Wang Aijun Resigns, Aaron Rosenberg Takes Over
BeiGene announced on July 18th that Aijun Wang, a senior executive of the company, has recently submitted a resignation application to seek external development opportunities. He will officially resi ... -
BeiGene (688235. SH): Chief Financial Officer Wang Aijun resigns due to seeking external development opportunities
On July 19, 2024, BeiGene (688235. SH) announced that its Chief Financial Officer, Wang Aijun, has recently submitted a resignation application to seek external development opportunities. He will off ... -
BeiGene Chief Financial Officer Resigns, Aaron Rosenberg Takes Over
New Beijing News (Reporter Zhang Zhaohui) On July 18th, BeiGene Bureau announced the appointment of Aaron Rosenberg as the company's Chief Financial Officer and appointed Rosenberg as a senior manage ... -
BeiGene responds to being sued again by AbbVie: denies allegations and will launch a firm defense
Southern Finance and Economics, September 12th - According to Interface News and Fierce Biotech, multinational pharmaceutical company AbbVie has recently sued BeiGene again for plagiarizing the trade ... -
BeiGene responds to investigation of company executives: the incident involving the employee has nothing to do with BeiGene
On the afternoon of October 25th, BeiGene's official WeChat account released a statement stating that BeiGene had learned that an employee of the company was cooperating with the relevant investigati ... -
BeiGene: An employee of the company is cooperating with the investigation and it is understood that the incident in question is not related to BeiGene
On the afternoon of October 25th, BeiGene's stock price fell by over 5% at one point. As of the close, BeiGene had fallen by over 3% in the A-share market and 0.6% in the Hong Kong stock market. On t ... -
BeiGene responds to employee cooperation investigation: the incident is not related to the company
On October 25th, there were rumors in the market that Yin Min, the Chief Commercial Officer of BeiGene Greater China, was under investigation by regulatory authorities. At 4:12 pm on the same day, Be ...